Y-Biologics, Inc. (KOSDAQ:338840)

Y-Biologics Statistics

Total Valuation

Y-Biologics has a market cap or net worth of KRW 207.05 billion. The enterprise value is 198.09 billion.

Market Cap	207.05B
Enterprise Value	198.09B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Y-Biologics has 14.95 million shares outstanding. The number of shares has increased by 7.36% in one year.

Current Share Class	14.95M
Shares Outstanding	14.95M
Shares Change (YoY)	+7.36%
Shares Change (QoQ)	-0.50%
Owned by Insiders (%)	29.34%
Owned by Institutions (%)	3.57%
Float	10.49M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	34.74
PB Ratio	12.67
P/TBV Ratio	12.98
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-31.99
EV / Sales	33.24
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-62.88

Financial Position

The company has a current ratio of 6.52, with a Debt / Equity ratio of 0.04.

Current Ratio	6.52
Quick Ratio	6.42
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	-0.22
Interest Coverage	-171.14

Financial Efficiency

Return on equity (ROE) is -32.72% and return on invested capital (ROIC) is -20.02%.

Return on Equity (ROE)	-32.72%
Return on Assets (ROA)	-18.41%
Return on Invested Capital (ROIC)	-20.02%
Return on Capital Employed (ROCE)	-36.68%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.28
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +16.73% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+16.73%
50-Day Moving Average	11,697.80
200-Day Moving Average	8,893.20
Relative Strength Index (RSI)	64.59
Average Volume (20 Days)	515,653

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Y-Biologics had revenue of KRW 5.96 billion and -6.19 billion in losses. Loss per share was -499.76.

Revenue	5.96B
Gross Profit	4.79B
Operating Income	-6.30B
Pretax Income	-6.19B
Net Income	-6.19B
EBITDA	-4.36B
EBIT	-6.30B
Loss Per Share	-499.76

Balance Sheet

The company has 9.65 billion in cash and 697.76 million in debt, giving a net cash position of 8.96 billion or 599.11 per share.

Cash & Cash Equivalents	9.65B
Total Debt	697.76M
Net Cash	8.96B
Net Cash Per Share	599.11
Equity (Book Value)	16.34B
Book Value Per Share	1,093.10
Working Capital	8.35B

Cash Flow

In the last 12 months, operating cash flow was -2.71 billion and capital expenditures -436.97 million, giving a free cash flow of -3.15 billion.

Operating Cash Flow	-2.71B
Capital Expenditures	-436.97M
Free Cash Flow	-3.15B
FCF Per Share	-210.74

Margins

Gross margin is 80.32%, with operating and profit margins of -105.78% and -103.90%.

Gross Margin	80.32%
Operating Margin	-105.78%
Pretax Margin	-103.90%
Profit Margin	-103.90%
EBITDA Margin	-73.08%
EBIT Margin	-105.78%
FCF Margin	n/a

Dividends & Yields

Y-Biologics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.36%
Shareholder Yield	n/a
Earnings Yield	-2.99%
FCF Yield	-1.52%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Y-Biologics has an Altman Z-Score of 23.86 and a Piotroski F-Score of 3.

Altman Z-Score	23.86
Piotroski F-Score	3